Literature DB >> 22534035

Birthweight and cytochrome P4503A4/5 activity in obese women.

Ganesh Cherala, Kent Thornburg, Alison Edelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22534035      PMCID： PMC3555069          DOI： 10.1111/j.1365-2125.2012.04309.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

Review 1.  Fetal programming and adult health.

Authors:  K M Godfrey; D J Barker
Journal:  Public Health Nutr       Date:  2001-04       Impact factor: 4.022

Review 2.  Developmental origins of the metabolic syndrome: prediction, plasticity, and programming.

Authors:  I Caroline McMillen; Jeffrey S Robinson
Journal:  Physiol Rev       Date:  2005-04       Impact factor: 37.312

Review 3.  Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU.

Authors:  Isabel Spriet; Wouter Meersseman; Jan de Hoon; Sandrina von Winckelmann; Alexander Wilmer; Ludo Willems
Journal:  Intensive Care Med       Date:  2009-01-09       Impact factor: 17.440

4.  Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women.

Authors:  Alison Edelman; Myrna Munar; Miriam R Elman; Dennis Koop; Ganesh Cherala
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

5.  Association between size at birth, truncal fat and obesity in adult life and its contribution to blood pressure and coronary heart disease; study in a high birth weight population.

Authors:  I Gunnarsdottir; B E Birgisdottir; R Benediktsson; V Gudnason; I Thorsdottir
Journal:  Eur J Clin Nutr       Date:  2004-05       Impact factor: 4.016

Review 6.  Effect of in utero and early-life conditions on adult health and disease.

Authors:  Peter D Gluckman; Mark A Hanson; Cyrus Cooper; Kent L Thornburg
Journal:  N Engl J Med       Date:  2008-07-03       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.